8-K: Core Scientific to be Acquired by CoreWeave in All-Stock Merger

Core Scientific, a leading blockchain infrastructure company, has entered into a definitive agreement to be acquired by CoreWeave, a specialized cloud provider, in an all-stock transaction.

Summary

• Core Scientific, Inc. (the 'Company') has entered into an Agreement and Plan of Merger with CoreWeave, Inc. ('Parent'), under which Core Scientific will become a wholly owned subsidiary of CoreWeave.
• Each outstanding share of Core Scientific common stock will be converted into the right to receive 0.1235 shares of CoreWeave Class A common stock.
• Company RSU Awards held by specified individuals (Adam Sullivan, Jim Nygaard, Todd DuChene) and non-employee directors will fully vest and convert into CoreWeave Class A common stock at the Exchange Ratio.
• Company PSU Awards held by specified individuals will vest at 300% performance level and convert into CoreWeave Class A common stock at the Exchange Ratio.
• Other Company RSU Awards and PSU Awards will be converted into Parent Rollover RSU Awards and Parent Rollover PSU Awards, respectively, subject to substantially the same terms and conditions, with PSU Awards vesting at a 300% performance level and becoming time-based.
• In-the-money Company Options will be cancelled and converted into CoreWeave Class A common stock based on a net option share amount multiplied by the Exchange Ratio; out-of-the-money options will be cancelled without consideration.
• Company Warrants (Tranche 1 and Tranche 2) will be converted into New Tranche 1 Warrants and New Tranche 2 Warrants, respectively, exercisable for CoreWeave Class A common stock with adjusted exercise prices and substantially similar terms.
• The merger is subject to customary closing conditions, including Core Scientific stockholder approval, effectiveness of CoreWeave's S-4 registration statement, expiration of the HSR Act waiting period, absence of injunctions, and Nasdaq listing approval for CoreWeave shares.
• The merger is intended to qualify as a reorganization for U.S. federal income tax purposes under Section 368(a) of the Code.
• Named executive officers and certain other executives will receive excise tax reimbursement agreements and lump sum cash severance payments upon separation from employment at closing, contingent on the merger's consummation and execution of a release of claims.

Sentiment

Score: 8

Explanation: The sentiment is highly positive due to the unanimous board approval, the strategic rationale of combining blockchain infrastructure with specialized cloud services, and the intention for the merger to be a tax-free reorganization. The detailed provisions for equity and warrant conversion, as well as executive compensation, suggest a well-planned and beneficial outcome for Core Scientific's stakeholders, despite the inherent risks of any large transaction.

Positives

• The Core Scientific Board unanimously determined the merger advisable, fair to, and in the best interests of the Company and its stockholders.
• The merger is an all-stock transaction, allowing Core Scientific shareholders to participate in the future growth of the combined entity, CoreWeave.
• Equity awards for specified individuals and non-employee directors will fully vest, and performance-based awards will vest at a 300% performance level, providing significant value to these individuals.
• The transaction is intended to qualify as a tax-free reorganization under Section 368(a) of the Code for U.S. federal income tax purposes.
• CoreWeave will provide severance benefits to Core Scientific employees that are no less favorable than existing terms, and will make commercially reasonable efforts to integrate employees into new benefit plans with service recognition and waiver of waiting periods.

Negatives

• The merger consideration is fixed at an exchange ratio of 0.1235 shares of CoreWeave Class A common stock per Core Scientific share, meaning Core Scientific shareholders are exposed to CoreWeave's stock price volatility until closing.
• Core Scientific will be subject to a $270 million termination fee payable to CoreWeave under specific circumstances, such as an Adverse Recommendation Change or termination to pursue a Superior Proposal.
• The agreement includes restrictions on Core Scientific's ability to solicit alternative acquisition proposals and engage in discussions with third parties, subject to customary exceptions.
• Named executive officers will separate from employment at the closing of the merger, indicating a change in leadership for Core Scientific's current management team.

Risks

• Completion of the proposed transaction on anticipated terms or at all, and the timing thereof, including obtaining regulatory approvals and Core Scientific stockholder approval.
• Unforeseen liabilities, future capital expenditures, revenues, expenses, earnings, synergies, economic performance, indebtedness, financial condition, losses, and future prospects of the combined company.
• The possibility that any anticipated benefits of the proposed transaction will not be realized or will not be realized within the expected time period.
• The ability of Core Scientific and CoreWeave to integrate their businesses successfully and to achieve anticipated synergies and value creation.
• Potential litigation relating to the proposed transaction that could be instituted against Core Scientific, CoreWeave, or their respective directors and officers.
• Disruptions from the proposed transaction harming Core Scientific's or CoreWeave's business, including current plans and operations, and diversion of management's time and attention.
• Potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction.
• Rating agency actions and Core Scientific's and CoreWeave's ability to access shortand long-term debt markets on a timely and affordable basis.
• Legislative, regulatory, and economic developments and actions targeting public companies in the artificial intelligence, power, data center, and crypto mining industries.
• Development delays at Core Scientific and/or CoreWeave's data center sites, including any delays in the conversion of such sites from crypto mining facilities to high-performance computing facilities.
• Price volatility of digital assets and bitcoin in particular.
• Potential changes in the interpretive positions of the SEC or its staff with respect to digital asset mining firms.
• The likelihood that U.S. federal and state legislatures and regulatory agencies will enact laws and regulations to regulate digital assets and digital asset intermediaries.

Future Outlook

The merger is expected to combine Core Scientific's blockchain infrastructure with CoreWeave's specialized cloud capabilities, with an intention for the transaction to qualify as a tax-free reorganization. The combined entity aims to achieve anticipated synergies and value creation, though risks related to integration, regulatory changes in the AI, power, data center, and crypto mining industries, and market conditions are acknowledged.

Management Comments

• The Core Scientific Board unanimously determined that the Agreement and the Contemplated Transactions are advisable, fair to, and in the best interests of the Company and its stockholders.
• The Core Scientific Board approved and deemed advisable the execution and delivery of the Agreement, the performance by the Company of its covenants and agreements, and the consummation of the Contemplated Transactions, including the Merger.

Industry Context

This merger represents a significant strategic move in the evolving digital infrastructure landscape, particularly at the intersection of cryptocurrency mining and high-performance computing (HPC). Core Scientific, a major player in blockchain infrastructure, is being acquired by CoreWeave, a specialized cloud provider. This aligns with a broader industry trend where traditional crypto mining facilities are being repurposed or expanded to support the growing demand for HPC, especially for artificial intelligence workloads, leveraging existing power and data center infrastructure.

Comparison to Industry Standards

• The all-stock nature of the transaction is common in strategic mergers, allowing shareholders of the acquired company to participate in the upside of the combined entity, similar to other notable tech mergers.
• The provision for executive excise tax gross-up payments and severance packages is a common feature in merger agreements, often referred to as 'golden parachutes,' designed to compensate executives for potential job loss and tax burdens related to change-in-control payments. These are standard practices in large corporate transactions to ensure management cooperation during the transition.
• The requirement for HSR Act approval and other regulatory clearances is standard for mergers of this scale in the U.S., reflecting the need to comply with antitrust laws and ensure fair competition, comparable to other significant acquisitions in the data center or technology sectors.

Management Changes

Corporate Governance

Legal Proceedings

• The document mentions 'Transaction Litigation' as a risk factor, referring to potential lawsuits challenging the merger or related disclosures.
• Covenants require Core Scientific and CoreWeave to promptly notify each other of any Transaction Litigation and provide an opportunity to participate in the defense, with neither party settling without the other's consent (unless monetary only).

Related Party Transactions

• Excise tax reimbursement agreements for named executive officers and certain other executives, providing gross-up payments for Section 4999 excise tax in connection with the Merger.
• Individual letter agreements for named executive officers and certain other executives, providing lump sum cash severance payments upon separation from employment at closing.

Stakeholder Impact

• **Shareholders (Core Scientific)**: Will receive CoreWeave Class A common stock, converting their ownership into a stake in the combined entity. The all-stock nature means their future value is tied to CoreWeave's performance.
• **Employees (Core Scientific)**: Current employees will receive comparable base salary, wages, and target cash incentive opportunities for one year post-merger. They will also be eligible for severance benefits and integration into CoreWeave's benefit plans with service recognition.
• **Management (Core Scientific)**: Named executive officers and certain other executives will separate from employment at closing, receiving significant severance and excise tax gross-up payments, subject to non-competition covenants.
• **Warrant Holders (Core Scientific)**: Warrants will be converted into new warrants exercisable for CoreWeave Class A common stock with adjusted terms, maintaining their economic interest in the combined entity.
• **Convertible Note Holders (Core Scientific)**: The Company will take actions required by the indentures for its convertible notes as a result of the merger, ensuring their rights are addressed.
• **Customers & Suppliers**: The merger is expected to preserve existing business relationships, though potential adverse reactions or changes are noted as a risk.

Next Steps

• Core Scientific to obtain Company Stockholder Approval for the merger.
• CoreWeave to file a registration statement on Form S-4 with the SEC, including Core Scientific's proxy statement.
• CoreWeave to seek effectiveness of the Form S-4 registration statement and listing approval for its Class A Common Stock on Nasdaq.
• Both parties to obtain HSR Act clearance and other necessary regulatory approvals.
• Core Scientific to take actions required by its Indentures for Convertible Notes and Warrant Agreement due to the merger.
• Core Scientific to purchase a D&O tail insurance policy prior to the Effective Time.
• Core Scientific to cooperate with CoreWeave in arranging debt financing, if requested.
• Core Scientific to cooperate in obtaining third-party consents for contracts.
• Core Scientific to cooperate in delisting its common stock and warrants from Nasdaq and deregistering under the Exchange Act after the Effective Time.
• Parent to post IRS Form 8937 on its website not later than 45 days after the Closing Date.

Key Dates

Recommendation

Keywords

Merger, Acquisition, Core Scientific, CoreWeave, All-stock transaction, Blockchain infrastructure, High-performance computing, Data center, Cryptocurrency mining, SEC filing, Form 8-K, Stockholder approval, Regulatory approval, Equity awards, Warrants, Corporate governance, Executive compensation